A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding
Abstract Antibody treatment is currently the only available countermeasure for botulism, a fatal illness caused by flaccid paralysis of muscles due to botulinum neurotoxin (BoNT) intoxication. Among the seven major serotypes of BoNT/A-G, BoNT/A poses the most serious threat to humans because of its...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/28d488b3904246b2b17c6304fa26a9f6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|